Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2007 | 1 |
2008 | 2 |
2009 | 1 |
2010 | 2 |
2012 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy.
Am J Physiol Renal Physiol. 2009 Sep;297(3):F585-93. doi: 10.1152/ajprenal.00186.2009. Epub 2009 May 27.
Am J Physiol Renal Physiol. 2009.
PMID: 19474189
Free PMC article.
Metabolic control by S6 kinases depends on dietary lipids.
Castañeda TR, Abplanalp W, Um SH, Pfluger PT, Schrott B, Brown K, Grant E, Carnevalli L, Benoit SC, Morgan DA, Gilham D, Hui DY, Rahmouni K, Thomas G, Kozma SC, Clegg DJ, Tschöp MH.
Castañeda TR, et al.
PLoS One. 2012;7(3):e32631. doi: 10.1371/journal.pone.0032631. Epub 2012 Mar 7.
PLoS One. 2012.
PMID: 22412899
Free PMC article.
Item in Clipboard
mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs.
Dowling RJ, Topisirovic I, Alain T, Bidinosti M, Fonseca BD, Petroulakis E, Wang X, Larsson O, Selvaraj A, Liu Y, Kozma SC, Thomas G, Sonenberg N.
Dowling RJ, et al.
Science. 2010 May 28;328(5982):1172-6. doi: 10.1126/science.1187532.
Science. 2010.
PMID: 20508131
Free PMC article.
Item in Clipboard
Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance.
Tremblay F, Brûlé S, Hee Um S, Li Y, Masuda K, Roden M, Sun XJ, Krebs M, Polakiewicz RD, Thomas G, Marette A.
Tremblay F, et al.
Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):14056-61. doi: 10.1073/pnas.0706517104. Epub 2007 Aug 20.
Proc Natl Acad Sci U S A. 2007.
PMID: 17709744
Free PMC article.
Item in Clipboard
Identifying optimal biologic doses of everolimus (RAD001) in patients with cancer based on the modeling of preclinical and clinical pharmacokinetic and pharmacodynamic data.
Tanaka C, O'Reilly T, Kovarik JM, Shand N, Hazell K, Judson I, Raymond E, Zumstein-Mecker S, Stephan C, Boulay A, Hattenberger M, Thomas G, Lane HA.
Tanaka C, et al.
J Clin Oncol. 2008 Apr 1;26(10):1596-602. doi: 10.1200/JCO.2007.14.1127. Epub 2008 Mar 10.
J Clin Oncol. 2008.
PMID: 18332467
Clinical Trial.
Item in Clipboard
Amino acids activate mTOR complex 1 via Ca2+/CaM signaling to hVps34.
Gulati P, Gaspers LD, Dann SG, Joaquin M, Nobukuni T, Natt F, Kozma SC, Thomas AP, Thomas G.
Gulati P, et al.
Cell Metab. 2008 May;7(5):456-65. doi: 10.1016/j.cmet.2008.03.002.
Cell Metab. 2008.
PMID: 18460336
Free PMC article.
Item in Clipboard
Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner.
Kalender A, Selvaraj A, Kim SY, Gulati P, Brûlé S, Viollet B, Kemp BE, Bardeesy N, Dennis P, Schlager JJ, Marette A, Kozma SC, Thomas G.
Kalender A, et al.
Cell Metab. 2010 May 5;11(5):390-401. doi: 10.1016/j.cmet.2010.03.014.
Cell Metab. 2010.
PMID: 20444419
Free PMC article.
Item in Clipboard
Cite
Cite